06 Feb 2019 --- Jennewein Biotechnologie, which specializes in the research and manufacture of human milk oligosaccharides (HMO), and Inner Mongolia Yili Industrial Group (Yili Group), China’s leading dairy company, have signed a Memorandum of Understanding on research into infant microbiome and HMOs. Their goal will be to develop an innovative infant formula and dairy products specifically tailored to the Chinese market – the largest market for baby food globally.
